PLSE CIK: 1625101

Pulse Biosciences Inc

  • United States
  • Healthcare
  • MedTech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
0.82
FY22:
−11.2
FY23:
0
FY24:
0
FY25:
−0.19
(positive)
Change from FY21 to FY25
millions USD
FY21:
−63.0
FY22:
−58.1
FY23:
−43.6
FY24:
−56.3
FY25:
−76.9
(positive)
Change from FY22 to FY25
millions USD
FY21:
–
FY22:
−56.7
FY23:
−42.4
FY24:
−55.1
FY25:
−75.9
(positive)
Change from FY21 to FY25
millions USD
FY21:
−63.7
FY22:
−58.5
FY23:
−42.2
FY24:
53.6
FY25:
72.8
(positive)
Change from FY21 to FY25
millions USD
FY21:
−63.7
FY22:
−58.5
FY23:
−42.2
FY24:
−53.6
FY25:
−72.8

All amounts in millions USD Data sources:SEC EDGARTwelve Data